Avantyo Newsletter My account Search

GCP Entry Level

This course presents the approach to clinical trial planning and execution as defined by the ICH Good Clinical Practice (GCP) standard and is a comprehensive training solution for all individuals that need to acquire GCP knowledge.

Not sure how to book? Click here for instructions in Romanian.


Newsletter

In order to be always informed about AVANTYO courses and events, please subscribe to our newsletter.

Waiting list

If you would like to be placed on a waiting list for the next course or you need something else, please let us know at info@avantyo.com. Do not forget to mention your specific education needs in clinical trials


Privacy Policy & GDPR

Attending a GCP course like ours is an essential requirement for any professional working in clinical trials from academia, professional clinical sites, Clinical Research Organizations (CROs), Sponsors, members of Ethics Committees or Competent Authorities, researchers or other research or medical staff.

Applying the GCP principles provides assurance that the rights, safety and well-being of research subjects are protected and that the results of the study are credible.

Successful attendance of our GCP online training as demonstrated in a final multiple-choice test will provide you with the internationally recognized “EFGCP GCP Certificate of Completion”. The course is recognized by TransCelerate Minimum Criteria of GCP Training Courses.

Ingrid Klingmann, MD, PhD, FFPM, FBCPM PHARMAPLEX bv, EFGCP, PharmaTrain Federation

Ingrid Klingmann, MD, PhD, European Forum for Good Clinical Practice (EFGCP), Pharmaplex bv, Brussels, has 30 years of practical experience with planning and performance of clinical trials from a sponsor and investigator perspective in the pharmaceutical industry, CRO and academic institution. Through her activities in multi-stakeholder not-for-profit organisations like EFGCP, she gained broad experience in ethical, quality and regulatory challenges in clinical research and possible approaches to solutions.

  • Physician, specialized in General Medicine, Clinical Pharmacology and Pharmaceutical Medicine with over 30 years of experience in different senior medical, operational and managerial functions in the pharmaceutical industry, CROs and clinical trial sites with focus on clinical trial design and management, ethical and regulatory aspects.
  • Since January 2003 she has her pharmaceutical development and site management support consulting company.
  • Dr Klingmann is Chairman of the Board of the European Forum for Good Clinical Practice (EFGCP). On behalf of EFGCP she was and is involved in different FP7- and IMI-funded projects (ICREL, PatientPartner, PharmaTrain, EUPATI, Combacte-NET, PARADIGM and ConCEPTION) and with her company in the FP7-funded paediatric LENA project. Her broad professional background as a physician with experience in patient care, clinical development, site management and patient engagement enables Dr Klingmann to bridge the gaps between the interests and skills of all different stakeholders in medicines development to develop new patient-relevant treatments more efficiently.
  • Dr Klingmann is also President of PharmaTrain Federation, the not-for-profit organisation focussing on global standardisation and improvement of post-graduate training in medicines development sciences. She also teaches on different clinical research and regulatory affairs topics in diploma and master courses at the University of Bonn, Germany, University of Basel, Switzerland, and the Université Libre de Bruxelles, Belgium.

Schedule

Registration closed

Find out about the next training date!

Login / register to subscribe